4d
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China
China Medical System Holdings Limited (the "Group" or "CMS") is pleased to announce that on 11 December 2025, the New Drug Application (NDA) of Class 1 Innovative Drug Y-3 for Injection (proposed ...
Devastating flash floods and landslides struck three provinces in Sumatra, namely Aceh, North Sumatra, and West Sumatra, in late November 2025. According to data from the National Disaster Mitigation ...
Leapfrog Acquisition Corporation (the "Company") announced today the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The units are expected to commence ...
■株主還元策 TOKAIホールディングス<a href="https://web.fisco.jp/platform/companies/0316700?fm=mj" target="_blank" rel="noopener ...
■今後の見通し 1. 2026年3月期の業績見通し TOKAIホールディングス<a href="https://web.fisco.jp/platform/companies/0316700?fm=mj" target="_blank" ...
■要約 TOKAIホールディングス<a href="https://web.fisco.jp/platform/companies/0316700?fm=mj" target="_blank" rel="noopener ...
セクターでは、非鉄金属、鉱業、証券商品先物が下落率上位となっている一方、空運業、水産・農林業、食料品が上昇している。東証プライム市場の売買代金上位では、三井海洋 ＜6269＞ 、三井E&S ＜7003＞ 、フジクラ ＜5803＞ 、安川電 ...
ニッソウ<a href="https://web.fisco.jp/platform/companies/0144400?fm=mj" target="_blank" rel="noopener ...
■フタバ産業<a href="https://web.fisco.jp/platform/companies/0724100?fm=mj" target="_blank" rel="noopener noreferrer">＜7241＞の業績動向 1 ...
■事業概要 1. 経営環境 フタバ産業<a href="https://web.fisco.jp/platform/companies/0724100?fm=mj" target="_blank" rel="noopener ...
■株主還元策 フタバ産業<a href="https://web.fisco.jp/platform/companies/0724100?fm=mj" target="_blank" rel="noopener ...
■成長戦略 1. 中期経営計画（2025～2027） 加藤製作所<a href="https://web.fisco.jp/platform/companies/0639000?fm=mj" target="_blank" rel="noopener ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback